Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,402 | 371 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,383 | 102 | $0 (2024) |
| GlaxoSmithKline, LLC. | $760.39 | 47 | $0 (2024) |
| PFIZER INC. | $496.87 | 33 | $0 (2024) |
| Amgen Inc. | $485.06 | 21 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $439.40 | 25 | $0 (2024) |
| Astellas Pharma US Inc | $393.41 | 19 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $366.01 | 8 | $0 (2024) |
| Lilly USA, LLC | $245.05 | 22 | $0 (2024) |
| Novo Nordisk Inc | $230.59 | 13 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $182.85 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,389 | 87 | PFIZER INC. ($260.90) |
| 2023 | $1,528 | 99 | ABBVIE INC. ($276.52) |
| 2022 | $1,703 | 90 | ABBVIE INC. ($539.59) |
| 2021 | $1,781 | 95 | AbbVie Inc. ($409.14) |
All Payment Transactions
371 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.04 | General |
| Category: DIABETES | ||||||
| 12/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: RESPIRATORY | ||||||
| 12/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.25 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/19/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: Obesity | ||||||
| 11/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: RESPIRATORY | ||||||
| 10/25/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $2.38 | General |
| Category: PAIN | ||||||
| 10/22/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: Obesity | ||||||
| 10/15/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: DIABETES | ||||||
| 10/08/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: RESPIRATORY | ||||||
| 10/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: IMMUNOLOGY | ||||||
| 10/02/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/13/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 09/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: RESPIRATORY | ||||||
| 09/09/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $30.32 | General |
| Category: Biological | ||||||
| 09/05/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.21 | General |
| Category: Obesity | ||||||
| 08/28/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: DIABETES | ||||||
| 08/16/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 08/14/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: Diabetes | ||||||
| 08/13/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $0.79 | General |
| Category: Biological | ||||||
| 08/12/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: NEUROSCIENCE | ||||||
| 08/07/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: Psychology/Psychiatric | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 417 | 540 | $217,091 | $27,967 |
| 2022 | 20 | 1,074 | 1,846 | $435,831 | $114,749 |
| 2021 | 18 | 887 | 1,616 | $317,855 | $105,080 |
| 2020 | 19 | 747 | 1,464 | $281,318 | $86,713 |
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 200 | 323 | $127,585 | $16,981 | 13.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 22 | 22 | $7,722 | $2,394 | 31.0% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 24 | 24 | $21,072 | $2,308 | 11.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 22 | 22 | $11,594 | $1,860 | 16.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $10,746 | $1,143 | 10.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 25 | 25 | $24,150 | $1,086 | 4.5% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 24 | 24 | $7,152 | $915.34 | 12.8% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 23 | 23 | $2,415 | $502.78 | 20.8% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 23 | 23 | $1,610 | $357.88 | 22.2% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 21 | 21 | $1,470 | $326.76 | 22.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 15 | 15 | $1,575 | $92.21 | 5.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 270 | 944 | $247,760 | $70,974 | 28.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 78 | 78 | $24,962 | $8,735 | 35.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 63 | 83 | $28,078 | $8,704 | 31.0% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2022 | 42 | 42 | $25,536 | $4,975 | 19.5% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 70 | 70 | $19,708 | $3,848 | 19.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 46 | 46 | $30,708 | $3,422 | 11.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 34 | 34 | $14,130 | $3,285 | 23.3% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 14 | 17 | $9,690 | $3,166 | 32.7% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2022 | 72 | 72 | $6,975 | $1,635 | 23.4% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 78 | 78 | $5,040 | $1,248 | 24.8% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 76 | 76 | $4,870 | $1,194 | 24.5% |
| G0443 | Brief face-to-face behavioral counseling for alcohol misuse, 15 minutes | Office | 2022 | 40 | 40 | $3,840 | $907.72 | 23.6% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2022 | 34 | 34 | $3,345 | $771.47 | 23.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 25 | 26 | $918.00 | $659.36 | 71.8% |
About Laurie Michlin, APN
Laurie Michlin, APN is a Physician Assistant healthcare provider based in Henderson, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1518917111.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Laurie Michlin, APN has received a total of $6,402 in payments from pharmaceutical and medical device companies, with $1,389 received in 2024. These payments were reported across 371 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($6,402).
As a Medicare-enrolled provider, Michlin has provided services to 3,125 Medicare beneficiaries, totaling 5,466 services with total Medicare billing of $334,509. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Henderson, NV
- Active Since 05/12/2006
- Last Updated 04/25/2023
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1518917111
Products in Payments
- NURTEC ODT (Drug) $535.95
- TRELEGY ELLIPTA (Drug) $488.62
- JARDIANCE (Drug) $445.63
- UBRELVY (Drug) $444.01
- VRAYLAR (Drug) $424.67
- Veozah (Drug) $352.25
- ELIQUIS (Drug) $250.64
- Repatha (Biological) $245.73
- FARXIGA (Drug) $227.21
- MOUNJARO (Drug) $168.45
- SHINGRIX (Biological) $137.74
- AREXVY (Drug) $134.03
- NEXLETOL (Drug) $129.13
- BRILINTA (Drug) $124.98
- LINZESS (Drug) $121.81
- RINVOQ (Biological) $121.20
- Wegovy (Drug) $120.52
- SPRAVATO (Drug) $112.34
- SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER (Device) $109.61
- ENTRESTO (Drug) $101.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Henderson
Anna Liang, Physician Assistant, PHYSICIAN ASSISTANT
Physician Assistant — Payments: $9,518
Rachel Tennis, Pa-C, PA-C
Physician Assistant — Payments: $8,011
Stephanie Shibata, Pa-C, PA-C
Physician Assistant — Payments: $7,733
Benjamin Reese, Pa-C, PA-C
Physician Assistant — Payments: $6,807
Andrea Alessi, Pa, PA
Physician Assistant — Payments: $6,647
Daniel Salmon, Pa, PA
Physician Assistant — Payments: $6,367